Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potentials and Pitfalls of Cross-Translational Models of Cognitive Impairment
Noor Z. Al Dahhan, Fernanda G. De Felice, Douglas P. Munoz
Frontiers in Behavioral Neuroscience (2019) Vol. 13
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Toward integrative approaches to study the causal role of neural oscillations via transcranial electrical stimulation
Valeriia Beliaeva, Iurii Savvateev, Valerio Zerbi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice
Iven-Alex von Mücke-Heim, Lidia Urbina-Treviño, Joeri Bordes, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 329-340
Open Access | Times Cited: 32
Mice in translational neuroscience: What R we doing?
Garikoitz Azkona, Rosario Sánchez‐Pernaute
Progress in Neurobiology (2022) Vol. 217, pp. 102330-102330
Open Access | Times Cited: 29
Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
Hasan Slika, Ziya Karimov, Paolo Alimonti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16316-16316
Open Access | Times Cited: 18
Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease
Désirée H. Veening-Griffioen, Guilherme S. Ferreira, Peter J.K. van Meer, et al.
European Journal of Pharmacology (2019) Vol. 859, pp. 172524-172524
Open Access | Times Cited: 49
Large Animal Models of Glioma: Current Status and Future Prospects
William H. Hicks, Cylaina E. Bird, Mark N. Pernik, et al.
Anticancer Research (2021) Vol. 41, Iss. 11, pp. 5343-5353
Open Access | Times Cited: 28
State‐of‐the‐art therapy for Down syndrome
Nicola Lorenzón, Juanluis Musoles‐Lleó, Federica Turrisi, et al.
Developmental Medicine & Child Neurology (2023) Vol. 65, Iss. 7, pp. 870-884
Closed Access | Times Cited: 11
Improving Cognition with Nutraceuticals Targeting TGF-β1 Signaling
Margherita Grasso, Giuseppe Caruso, Justyna Godos, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1075-1075
Open Access | Times Cited: 24
Age-Related Perioperative Neurocognitive Disorders: Experimental Models and Druggable Targets
Odmara L. Barreto Chang, Katherine L. Possin, Mervyn Maze
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 321-340
Open Access | Times Cited: 17
Reversal of Age-Related Neuronal Atrophy by α5-GABAA Receptor Positive Allosteric Modulation
Thomas D. Prévot, Akiko Sumitomo, Toshifumi Tomoda, et al.
Cerebral Cortex (2020) Vol. 31, Iss. 2, pp. 1395-1408
Open Access | Times Cited: 26
Neurophysiology of the Developing Cerebral Cortex: What We Have Learned and What We Need to Know
Heiko J. Luhmann
Frontiers in Cellular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 11
Review of Plant Extracts and Active Components: Mechanisms of Action for the Treatment of Obesity-Induced Cognitive Impairment
Ike dela Peña, Timothy Afable, Vina Rose Dahilig-Talan, et al.
Brain Sciences (2023) Vol. 13, Iss. 6, pp. 929-929
Open Access | Times Cited: 6
Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis
Dan Shi, Mengyu Han, Weilin Liu, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2020) Vol. 35
Open Access | Times Cited: 16
Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1
Sara H. Osum, Adrienne L. Watson, David A. Largaespada
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1954-1954
Open Access | Times Cited: 14
The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development
Elsa Ghirardini, Francesco Calugi, Giulia Sagona, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1123-1123
Open Access | Times Cited: 11
CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models
Mahdi Barazesh, Shiva Mohammadi, Yadollah Bahrami, et al.
Current Gene Therapy (2020) Vol. 21, Iss. 2, pp. 130-148
Closed Access | Times Cited: 11
Behavioral shaping of rhesus macaques using the Cambridge neuropsychological automated testing battery
Robert G. Wither, Susan E. Boehnke, Ann Lablans, et al.
Journal of Neuroscience Methods (2020) Vol. 342, pp. 108803-108803
Closed Access | Times Cited: 10
A rodent model for long-term vagus nerve stimulation experiments
Farid Yaghouby, Benjamin Shafer, Srikanth Vasudevan
Bioelectronics in Medicine (2019) Vol. 2, Iss. 2, pp. 73-88
Open Access | Times Cited: 6
Western diet-induced obesity results in brain mitochondrial dysfunction in female Ossabaw swine
Taylor J. Kelty, Chris Taylor, Nicole Wieschhaus, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 2
The Evolution of Genome‐Editing Technologies
Hafiz Ishfaq Ahmad, Noreena Bibi, Abdul Jabbar
(2024), pp. 171-188
Closed Access
Akdeniz Diyet Bileşenlerinin Bilişsel Sağlık Üzerine Etkisi
Merve Esra Çıtar Dazıroğlu, Gamze Akbulut
Journal of Nutrition and Dietetics (2024) Vol. 52, Iss. 1, pp. 117-122
Open Access
Application of Cognitive Test Outcomes for Clinical Drug Development
Chris J. Edgar
(2024), pp. 279-294
Closed Access
Administering a Behavioral Test Battery in Rodents
Emily J. Jaehne, Michelle Corrone, Maarten van den Buuse
Methods in molecular biology (2023), pp. 87-100
Closed Access | Times Cited: 1
Cognitive Go/No-Go decision-making criteria in Alzheimer’s disease drug development
Alette M. Wessels, Chris J. Edgar, Pradeep J. Nathan, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 5, pp. 1330-1336
Closed Access | Times Cited: 3
Riding brain “waves” to identify human memory genes
H. C. Moore, Bradley Lega, Geneviève Konopka
Current Opinion in Cell Biology (2022) Vol. 78, pp. 102118-102118
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top